Attenuation of N-Nitrosodiethylamine -Induced Hepatocellular Carcinoma by Piceatannol and/or Cisplatin: The Interplay between Nuclear Factor (Erythroid Derived 2)-like 2 and Redox Status

BACKGROUND: The natural compound’s alternative and complementary uses have increased hopes for hepatocellular cancer treatment (HCC). OBJECTS: The goal of this study was to see if Piceatannol (PIC) in combination with cisplatin has a synergistic effect on N, N-nitrosodiethylamine (DEN)-induced HCC i...

Descripción completa

Detalles Bibliográficos
Autores principales: Salama, Omnia AM, Moawed, Fatma SM, Moustafa, Enas M, Kandil, Eman I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930969/
https://www.ncbi.nlm.nih.gov/pubmed/36444603
http://dx.doi.org/10.31557/APJCP.2022.23.11.3895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930969/
https://www.ncbi.nlm.nih.gov/pubmed/36444603
http://dx.doi.org/10.31557/APJCP.2022.23.11.3895

Ejemplares similares